Skip to content

To evaluate the effect of Ayurvedic medicines in Amlapitta, a condition similar to non-ulcer dyspepsia

A Clinical Study to Evaluate the Efficacy of Chinnodbhavadi Kwath and Drakshadi Gutika in the Management of Amlapitta - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108069
Enrollment
50
Registered
2026-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Sponsors

Arpita Jain
Lead Sponsor
Dr Megha Dixit
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: With Classical Symptoms of Amlapitta irrespective of caste,gender,occupation and economic status attending the O.P.D./I.P.D. of attached hospitals of Shri Dhanwantari Ayurvedic Medical College and Research Centre,Mathura U.P. Chronicity less than 1 year Presence of pratyatma lakshanas of Amlapitta

Exclusion criteria

Exclusion criteria: Patients below 20 years and above 60 years of age. Amlapitta patients on regular medications of other chronic metabolic diseases such as Diabetes,Hypertention.CKD,CAD patients etc. Patients suffering from AIDS,Carcinomas etc. and on therapies like Chemotherapy,Dialysis,Blood transfusions etc. Womens under ANC and lactating mothers as well. Chronicity more than 1 year Patients with any Gastro intestinal complications like peptic ulcer,perforation,stenosis etc. Patients having intolerance to trial drugs. Patients not willing to give informed consent for the trial.

Design outcomes

Primary

MeasureTime frame
Chinodbhavadi kwath and Drakshadi gutika will be equally effective in Amlapitta vyadh, For Amlapitta vyadhi, the primary outcome measures may be relief in symptoms - Reduction in Aruchi (loss of appetite) - Decrease in Hritkanthadaha (heartburn) - Improvement in Avipaka (digestion)Timepoint: 8 weeks

Secondary

MeasureTime frame
Secondary outcomes might include: - Quality of life improvements - Reduction in antacid dependency - Recurrence rates - Changes in Pitta-related symptomsTimepoint: 8 weeks

Countries

India

Contacts

Public ContactDr Megha Dixit

Shri Dhanwantari Ayurvedic Medical College and Research Centre

drmeghadixit90@gmail.com9671821339

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026